I’m an oncologist. This is why cancer is rising in the under-50s - The Telegraph

Direct Source Verification: This story is aggregated from The Telegraph (telegraph.co.uk). Full reporting rights and copyright belong to the primary publisher.
Prof Swanton believes inflammation could be the missing piece of the puzzle in understanding how tumours develop Credit: Rii Schroer Charles Swanton Published 15 November 2026 6:00am GMT Our series The Expert View brings you specialist health advice from professionals. In this ar...

Prof Swanton believes inflammation could be the missing piece of the puzzle in understanding how tumours develop Credit: Rii Schroer Charles Swanton Published 15 November 2026 6:00am GMT Our series The Expert View brings you specialist health advice from professionals. In this article, we hear from Prof Charles Swanton, a leading cancer researcher, professor of cancer medicine at University College London, clinical director at the Francis Crick Institute and consultant oncologist specialising in lung cancer. His research focuses on how cancers develop, evolve and become resistant to treatment.

When I was a registrar at the Royal Marsden Hospital back in 2004, I decided to investigate how many patients under 50 had been diagnosed with bowel cancer over the previous five years. It took me a long time trawling through medical notes to find fewer than 50 cases.

Today, I run a meeting examining the genetics of cancer patients, and almost every week we discuss at least one case of bowel cancer in someone under 50, sometimes two or three. Such cases were unusual as recently as 10 years ago. While this is anecdotal, the trend seems to mirror the data showing a rise in cases.

Recent figures from the World Cancer Research Fund show more than half a dozen types of cancer increasing among younger people (those aged 20-49) in England, including prostate, bowel, kidney, uterine, breast, pancreatic and liver cancer. Prostate cancer diagnoses in under-50s have almost quadrupled since 2001, while bowel, kidney and uterine cancers have more than doubled.

As a cancer scientist who also treats patients, I find these developments deeply concerning. But I also want to put them into perspective. Early-onset bowel cancer remains relatively uncommon. We’re talking about an increase from roughly four to eight cases per 100,000 people. Compare that with smoking-related lung cancer in older patients, where incidence can be around 300 cases per 100,000.

We mustn’t frighten people unnecessarily. Nor should we pretend there is one simple explanation for what is happening.

I suspect the reasons are complex and varied, even within individual cancer types.

Some of the increases may reflect better detection. With prostate cancer, for example, more men are aware of PSA testing and are requesting it from their GPs. The more you test, the more cancers you find.

Other explanations are biological. Take breast cancer. Women are having fewer children and having them later, both recognised risk factors. Young women are also starting their periods earlier – potentially related to changes in diet and calorie intake – which is also associated with an increased risk.

Biologically, having children earlier may reduce breast cancer risk, but that isn’t always compatible with the economic pressures of modern life.

Then there is obesity, which is associated with several cancers, including bowel, liver, pancreatic, kidney, endometrial and postmenopausal breast cancer.

But the really important question is why obesity is associated with cancer. And that brings me to one of the most exciting discoveries in cancer research in recent years.

For years, scientists believed cancer was driven primarily by mutations in a cell’s DNA. Until relatively recently, I was convinced that cancer was a disease of a single cell, almost exclusively dependent on acquiring advantageous mutations within that first cell.

But we’re increasingly discovering that mutations alone are often insufficient. We now know from studies of healthy human tissue that billions of cells in a healthy 60-year-old carry mutations associated with cancer, and these become increasingly common as we age. Yet these cells almost never develop into tumours.

The field’s growing suspicion is that inflammation could be the missing piece of the puzzle, helping to explain why only one cell carrying a cancer mutation becomes malignant while billions of others don’t. We still don’t understand precisely how this happens, but identifying the mechanism could transform cancer prevention.

The reasons behind this could include air pollution. Research published in Nature in 2023 demonstrated how air pollution could promote lung cancer by triggering an inflammatory response in tissue already carrying cancer-associated mutations.

Obesity is also associated with chronic inflammation. So are smoking and chronic alcohol consumption. There is emerging evidence that certain dietary patterns, such as the consumption of ultra-processed foods, may also contribute to chronic inflammation in the bowel.

Obesity is associated with chronic inflammation, which scientists believe could play a key role in the development of cancer Credit: Everyday Images / Alamy Stock Photo The childhood bacteria that could help explain bowel cancer in the youngThere is an intriguing possibility that exposure to certain bacteria during childhood could contribute to cancers developing decades later.

This concerns a strain of E. coli that produces a toxin called colibactin, which is capable of damaging DNA.

A 2025 study published in Nature, analysing almost 1,000 bowel cancer genomes, identified distinctive patterns of DNA damage associated with this toxin. Remarkably, these genetic signatures were around three times more common in patients diagnosed under 40 than in those over 70.

Why might younger generations be exposed more frequently? Have our diets changed? Are the bacteria more prevalent? Could something be affecting the protective lining of our intestines, allowing bacteria to reach vulnerable cells?

We simply don’t know. But these are promising avenues of investigation that the Cancer Research UK Grand Challenge teams are working on.

There is also evidence of a birth-cohort effect: people born in the 1980s and 1990s appear to face a greater risk of early-onset bowel cancer than those born decades earlier.

Something may have changed in our environment or lifestyles, but identifying it is an enormous scientific challenge. After all, most of us struggle to remember what we ate yesterday, let alone when we were 13.

One important question is whether obesity itself increases cancer risk or whether something in the foods associated with weight gain is responsible. Ultra-processed foods have attracted considerable attention, and there is emerging evidence linking them with bowel polyps, which can be precursors to cancer.

A 2025 study involving more than 29,000 women found that those consuming the most ultra-processed foods had a 45 per cent higher chance of developing conventional bowel adenomas – growths that can precede cancer – than those consuming the least.

But an association is not proof of causation. We don’t yet know whether it is excess calorie intake, particular ingredients or something else that might be responsible. Microplastics and other environmental exposures are also being investigated, but we don’t have the evidence to say they are driving the rise.

It’s important to be clear about these uncertainties. Many younger patients with bowel cancer have never been obese, which is another reason I don’t believe weight gain and sedentary lifestyles explain the whole story.

Many younger patients with bowel cancer have never been obese, says Prof Swanton  Credit: Rii Schroer The cancer vaccine I hope to see in my lifetimeUltimately, the greatest hope lies in understanding why some mutated cells become cancers while billions of others don’t.

My ambition over the next decade is to help prevent lung cancer. At UCL and Oxford, we are working with colleagues on LungVax, a vaccine approach initially intended to prevent lung cancer.

We’re also investigating whether blocking particular inflammatory pathways could reduce the risk of both lung cancer and cardiovascular disease. Imagine being able to intervene before cancer develops, rather than waiting until it needs treatment. Imagine a world where we could delay or prevent more cancers and cardiovascular disease. That is what excites me most.

It was back at Barts medical school in 1991 that I decided to specialise in oncology after a close family member was diagnosed with lymphoma. After he was successfully treated with chemotherapy and radiotherapy, I realised painstaking scientific and medical research conducted years before his diagnosis could save lives, and I wanted to be part of that. More than 30 years later, that remains my motivation, and I am as excited about the potential of discovery science to improve patients’ lives as ever.

Cancer prevention is a slow scientific process. But I believe we’re beginning to understand the missing pieces of the puzzle better than ever before. And that gives me enormous hope.

People often ask me to rank the lifestyle changes that could reduce cancer risk. My answer is simple: don’t smoke. Smoking remains the biggest avoidable cancer risk factor by a long way. It also increases the risk of heart attacks, strokes and vascular dementia.

I do not smoke, and I would urge anyone who does to stop. It’s never too late. While I’m confident vaping is safer than smoking cigarettes, we don’t know how much safer because the long-term evidence isn’t there yet. I certainly wouldn’t advise a non-smoker to start vaping, and I’m concerned by UK data showing that there are more than a million adults who were never regular smokers but now vape regularly.

It’s also important not to suggest that tobacco, red meat, obesity and air pollution all carry equivalent risks. They don’t. Smoking trumps everything.

Alcohol is another established cancer risk factor, particularly for bowel, breast and liver cancers. There is no completely safe amount I can recommend. But I still drink wine when I’m socialising with friends or attending work dinners.

I recognise the risks and try to reduce my exposure to other cancer risk factors where I can.

I was quite overweight as a child, and I’m naturally greedy. I love a good burger, dining with friends and, yes, I snack on biscuits and cake. But I try to limit fatty foods and excessive carbohydrates and eat plenty of fruit and vegetables, which fortunately I genuinely enjoy.

I’m also conscious of balancing what I consume with the energy I expend. At the end of each day, I roughly calculate whether I’ve eaten more calories than I’ve used. If I’ve overindulged, I might exercise a little more over the weekend. It’s a slightly unusual approach, perhaps, but it works for me.

Try to limit fatty foods and excessive carbohydrates and eat plenty of fruit and vegetables Credit: Yiu Yu Hoi/d3sign Find an exercise routine you genuinely enjoyI’m not a natural athlete, but at 54 I’ve discovered cycling and cover around 100km a week. I also cycle to work whenever possible.

I’ve recently taken up tennis and running too. I’m a terrible tennis player and an even worse runner, but the key is finding an activity you enjoy. Exercise helps control appetite and weight, which matters because obesity is associated not only with cancer but also diabetes, cardiovascular disease and joint problems. It also boosts your mood and takes your mind off work pressures.

My own habits aren’t perfect. I’m a chronic insomniac, often sleeping just four or five hours a night and waking repeatedly.

We don’t yet understand the relationship between sleep, stress and cancer particularly well, so I wouldn’t claim my poor sleep is causing cancer. But I do worry about its implications for my long-term health.

Original Source
https://www.telegraph.co.uk/health-fitness/conditions/cancer/oncologist-why-cancer-is-rising-in-under-50s/
Visit The Telegraph ↗
SHARE STORY:
𝕏 f in

Related Coverage in Health